Correlation Between Ligand Pharms and Berkshire Hathaway
Can any of the company-specific risk be diversified away by investing in both Ligand Pharms and Berkshire Hathaway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ligand Pharms and Berkshire Hathaway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ligand Pharms Glucagon and Berkshire Hathaway, you can compare the effects of market volatilities on Ligand Pharms and Berkshire Hathaway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ligand Pharms with a short position of Berkshire Hathaway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ligand Pharms and Berkshire Hathaway.
Diversification Opportunities for Ligand Pharms and Berkshire Hathaway
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ligand and Berkshire is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Ligand Pharms Glucagon and Berkshire Hathaway in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Berkshire Hathaway and Ligand Pharms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ligand Pharms Glucagon are associated (or correlated) with Berkshire Hathaway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Berkshire Hathaway has no effect on the direction of Ligand Pharms i.e., Ligand Pharms and Berkshire Hathaway go up and down completely randomly.
Pair Corralation between Ligand Pharms and Berkshire Hathaway
Assuming the 90 days horizon Ligand Pharms Glucagon is expected to generate 44.31 times more return on investment than Berkshire Hathaway. However, Ligand Pharms is 44.31 times more volatile than Berkshire Hathaway. It trades about 0.58 of its potential returns per unit of risk. Berkshire Hathaway is currently generating about -0.08 per unit of risk. If you would invest 0.19 in Ligand Pharms Glucagon on January 26, 2024 and sell it today you would earn a total of 0.11 from holding Ligand Pharms Glucagon or generate 57.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 13.64% |
Values | Daily Returns |
Ligand Pharms Glucagon vs. Berkshire Hathaway
Performance |
Timeline |
Ligand Pharms Glucagon |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Berkshire Hathaway |
Ligand Pharms and Berkshire Hathaway Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ligand Pharms and Berkshire Hathaway
The main advantage of trading using opposite Ligand Pharms and Berkshire Hathaway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ligand Pharms position performs unexpectedly, Berkshire Hathaway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Berkshire Hathaway will offset losses from the drop in Berkshire Hathaway's long position.Ligand Pharms vs. Niagara Mohawk Power | Ligand Pharms vs. The Siam Cement | Ligand Pharms vs. Oaktree Capital Group |
Berkshire Hathaway vs. American International Group | Berkshire Hathaway vs. Arch Capital Group | Berkshire Hathaway vs. Sun Life Financial | Berkshire Hathaway vs. Hartford Financial Services |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |